7-氯-4-(1-哌嗪基)喹啉结构式
|
常用名 | 7-氯-4-(1-哌嗪基)喹啉 | 英文名 | 7-Chloro-4-(piperazin-1-yl)quinoline |
|---|---|---|---|---|
| CAS号 | 837-52-5 | 分子量 | 247.72300 | |
| 密度 | 1.257 g/cm3 | 沸点 | 433.5ºC at 760 mmHg | |
| 分子式 | C13H14ClN3 | 熔点 | 113-116ºC | |
| MSDS | N/A | 闪点 | 216ºC |
7-氯-4-(1-哌嗪基)喹啉用途7-氯-4-(哌嗪-1-基)喹诺酮类药物是一种重要的药物化学支架。7-氯-4-(哌嗪-1-基)喹诺酮类药物是一种有效的sirtuin抑制剂,并可抑制5-羟色胺摄取(IC50为50μM)。7-氯-4-(哌嗪-1-基)喹诺酮类药物对P。IC50分别为1.18μM和0.97μM的恶性疟原虫[1]。 |
| 中文名 | 7-氯-4-(1-哌嗪基)喹啉 |
|---|---|
| 英文名 | 7-Chloro-4-(piperazin-1-yl)quinoline |
| 中文别名 | 7-氯-4-哌嗪-1-基喹啉 | 7-氯-4-哌嗪基喹啉 |
| 英文别名 | 更多 |
| 描述 | 7-氯-4-(哌嗪-1-基)喹诺酮类药物是一种重要的药物化学支架。7-氯-4-(哌嗪-1-基)喹诺酮类药物是一种有效的sirtuin抑制剂,并可抑制5-羟色胺摄取(IC50为50μM)。7-氯-4-(哌嗪-1-基)喹诺酮类药物对P。IC50分别为1.18μM和0.97μM的恶性疟原虫[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.257 g/cm3 |
|---|---|
| 沸点 | 433.5ºC at 760 mmHg |
| 熔点 | 113-116ºC |
| 分子式 | C13H14ClN3 |
| 分子量 | 247.72300 |
| 闪点 | 216ºC |
| 精确质量 | 247.08800 |
| PSA | 28.16000 |
| LogP | 2.69160 |
| InChIKey | DNXNPMDUDGUXOB-UHFFFAOYSA-N |
| SMILES | Clc1ccc2c(N3CCNCC3)ccnc2c1 |
| 外观性状 | 淡黄色固体 |
| 折射率 | 1.636 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | C: Corrosive; |
|---|---|
| 风险声明 (欧洲) | R34 |
| 安全声明 (欧洲) | S22-S26-S36/37/39-S45 |
| 海关编码 | 2933990090 |
|
~98%
7-氯-4-(1-哌嗪基)喹啉 837-52-5 |
| 文献:Youngsaye, Willmen; Vincent, Benjamin; Hartland, Cathy L.; Morgan, Barbara J.; Buhrlage, Sara J.; Johnston, Stephen; Bittker, Joshua A.; MacPherson, Lawrence; Dandapani, Sivaraman; Palmer, Michelle; Whitesell, Luke; Lindquist, Susan; Schreiber, Stuart L.; Munoz, Benito Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 18 p. 5502 - 5505 |
| 7-氯-4-(1-哌嗪基)喹啉上游产品 2 | |
|---|---|
| 7-氯-4-(1-哌嗪基)喹啉下游产品 2 | |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Cytotoxicity against human HeLa cells after 7 days by MTT assay
来源:ChEMBL
靶标:HeLa
External Id:CHEMBL1772871
|
|
实验名称:Cytotoxicity against phytohaemagglutinin-stimulated human lymphocytes after 3 days by...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1772873
|
|
实验名称:Cytotoxicity against human resting lymphocytes after 3 days by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1772872
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
来源:Burnham Center for Chemical Genomics
靶标:N/A
External Id:BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
实验名称:Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum Dd2 t...
来源:ChEMBL
靶标:Plasmodium falciparum
External Id:CHEMBL1772874
|
|
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
|
| 7-chloro-4-piperazin-1-ylquinoline |